tiprankstipranks
Trending News
More News >
Alembic Pharmaceuticals Limited (IN:APLLTD)
:APLLTD
India Market

Alembic Pharmaceuticals Limited (APLLTD) Income Statement

Compare
1 Followers

Alembic Pharmaceuticals Limited Income Statement

Last quarter (Q4 2025), Alembic Pharmaceuticals Limited's total revenue was ₹17.70B, an increase of 16.66% from the same quarter last year. In Q4, Alembic Pharmaceuticals Limited's net income was ₹1.57B. See Alembic Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 66.72B₹ 62.29B₹ 56.53B₹ 52.32B₹ 52.76B
Gross Profit
₹ 48.79B₹ 22.69B₹ 39.44B₹ 35.09B₹ 37.55B
Operating Expenses
₹ 15.62B₹ 15.87B₹ 35.11B₹ 29.16B₹ 24.58B
Depreciation and Amortization
₹ 2.79B₹ 2.73B₹ 2.75B₹ 2.87B₹ 1.83B
EBITDA
₹ 10.08B₹ 9.62B₹ 7.11B₹ 9.25B₹ 15.68B
Operating Income
₹ 33.16B₹ 5.76B₹ 4.38B₹ 5.87B₹ 12.97B
Other Income/Expenses
₹ -26.09B₹ 560.20M₹ -338.00M₹ -12.11B₹ -9.63B
Pretax Income
₹ 7.07B₹ 6.32B₹ 3.55B₹ 6.20B₹ 13.68B
Net Income
₹ 5.83B₹ 6.16B₹ 3.42B₹ 5.21B₹ 11.46B
Per Share Metrics
Basic EPS
₹ 29.68₹ 31.33₹ 17.40₹ 26.50₹ 59.18
Diluted EPS
₹ 29.68₹ 31.33₹ 17.40₹ 26.50₹ 59.18
Weighted Average Shares Outstanding
196.57M 196.56M 196.56M 196.56M 193.74M
Weighted Average Shares Outstanding (Diluted)
196.57M 196.56M 196.56M 196.56M 193.74M
Currency in INR

Alembic Pharmaceuticals Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis